Unicycive Therapeutics, Inc. Common Stock (UNCY) is a publicly traded Healthcare sector company. As of July 31, 2026, UNCY trades at $4.98 with a market cap of $145.18M and a P/E ratio of -3.01. UNCY moved -5.38% today. Year to date, UNCY is -13.62%; over the trailing twelve months it is +15.44%. Its 52-week range spans $3.71 to $11.00. Analyst consensus is strong buy with an average price target of $36.71. Rallies surfaces UNCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover UNCY: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $36.71.
| Metric | Value |
|---|---|
| Price | $4.98 |
| Market Cap | $145.18M |
| P/E Ratio | -3.01 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.00 |
| 52-Week Low | $3.71 |
| Volume | 451.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.55M |
| Gross Margin | 0.00% |
7 analysts cover UNCY: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $36.71.